(Press-News.org) Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to its high mortality. This is particularly pronounced in low-resource settings where access to advanced, costly diagnostic tools is limited. There is a pressing need for affordable, non-invasive, and accessible diagnostic strategies. This review underscores the significant potential of hematological and biochemical serum markers as pivotal tools to bridge this diagnostic gap, offering insights into diagnosis, prognosis, and therapeutic monitoring for breast cancer.
Hematological Markers Associated with Breast Cancer
Hematological markers, derived from routine and inexpensive tests like the complete blood count (CBC), provide a window into the body's physiological and pathological state, including systemic inflammation and immune response, which are hallmarks of cancer.
Formed Elements: Studies consistently show significant alterations in the cellular components of blood in breast cancer patients. These include decreases in hemoglobin (Hb) and red blood cell (RBC) counts (indicating anemia), and changes in white blood cell (WBC) populations. Notably, levels of lymphocytes, neutrophils, and monocytes often show statistically significant differences compared to healthy individuals, reflecting the tumor's interaction with the immune system.
Neutrophil-to-Lymphocyte Ratio (NLR): The NLR has emerged as a robust prognostic indicator. A higher NLR is consistently associated with poorer outcomes, including shorter disease-free and overall survival, particularly in aggressive subtypes like HER2-positive and triple-negative breast cancer. Its value lies in reflecting a pro-tumor inflammatory environment.
Platelet-to-Lymphocyte Ratio (PLR): Elevated PLR is another key marker linked to more aggressive tumor characteristics, such as lymph node involvement and higher tumor grade. Platelets are thought to promote tumor growth and metastasis by releasing growth factors and shielding cancer cells from immune surveillance.
Erythrocyte Sedimentation Rate (ESR): As a nonspecific marker of inflammation, ESR levels are significantly elevated in breast cancer patients compared to healthy controls, and high levels have been correlated with a worse prognosis.
Biochemical Serum Markers Associated with Breast Cancer
Serum biochemical markers offer complementary information on metabolic and organ function, which can be perturbed by cancer progression and metastasis.
Enzymes: Lactate dehydrogenase (LDH) and alkaline phosphatase (ALP) are particularly significant. Elevated LDH is associated with tumor progression and metastasis, while a rise in ALP often serves as an important indicator of bone or liver metastasis.
Creatine Kinase-BB: This isoenzyme may not be a reliable marker for malignancy itself but shows promise as an indicator of hormone dependency in breast cancer.
Serum Uric Acid (SUA): The role of SUA is complex and dualistic, acting as both an antioxidant and a pro-inflammatory agent. The relationship between SUA levels and breast cancer risk appears to be J-shaped, where both very low and very high levels may be detrimental.
C-Reactive Protein (CRP): As a sensitive marker of systemic inflammation, CRP levels are markedly elevated in breast cancer patients and are linked to increased tumor burden and poorer survival outcomes.
Cancer Antigens (CA 15-3 & CA 27.29): These are among the most reliable serum markers for monitoring disease in advanced-stage breast cancer, effectively tracking treatment response, recurrence, and metastatic spread.
D-dimer: Elevated plasma D-dimer levels are associated with advanced disease, larger tumor size, and metastasis, reflecting the activation of coagulation pathways in cancer progression.
Oxidative Stress Markers: Reactive oxygen species (ROS) play a pivotal role in breast cancer. Markers like 4-hydroxynonenal (4-HNE) are elevated, while antioxidant enzymes like catalase are decreased in patients, offering a non-invasive glimpse into the oxidative stress associated with tumorigenesis.
Systemic Biomarkers for Breast Cancer Management
The true value of these markers lies in their integration into a systemic, multi-modal diagnostic framework. While individually they may lack specificity for early detection, their combined use can significantly enhance risk stratification, prognosis, and monitoring. For instance, combining NLR and PLR with tumor immune features can improve prognostic accuracy. However, challenges remain, including low specificity, susceptibility to influence by non-cancerous conditions (e.g., infection, obesity), and the need for technical simplification for markers like those related to oxidative stress. Therefore, they are best utilized as complementary tools alongside clinical examination and imaging, rather than as stand-alone diagnostics.
Future Directions
Future research should focus on standardizing assessment protocols and leveraging emerging technologies like liquid biopsy and machine learning to analyze multiple biomarkers simultaneously. Exploring the interplay between hematological markers, oxidative stress, and genetic factors could uncover novel therapeutic targets. Expanding access to these affordable tools is crucial for reducing global disparities in breast cancer outcomes.
Conclusions
Hematological and serum-based biomarkers represent a promising avenue for improving breast cancer care, especially in resource-limited settings. Markers such as NLR, PLR, CA 15-3, and oxidative stress indicators provide valuable, cost-effective, and non-invasive insights into tumor-associated inflammation and disease progression. Their integration into structured, multi-modal diagnostic strategies holds the potential to enable earlier detection, guide personalized treatment, and ultimately contribute to more equitable breast cancer management worldwide.
Full text:
https://xiahepublishing.com/2472-0712/ERHM-2025-00022
The study was recently published in the Exploratory Research and Hypothesis in Medicine.
Exploratory Research and Hypothesis in Medicine (ERHM) publishes original exploratory research articles and state-of-the-art reviews that focus on novel findings and the most recent scientific advances that support new hypotheses in medicine. The journal accepts a wide range of topics, including innovative diagnostic and therapeutic modalities as well as insightful theories related to the practice of medicine. The exploratory research published in ERHM does not necessarily need to be comprehensive and conclusive, but the study design must be solid, the methodologies must be reliable, the results must be true, and the hypothesis must be rational and justifiable with evidence.
END
Japan is facing the urgent challenge of aging infrastructure, amidst ineffective linking of on-site experience and expertise with vast amounts of digital data in maintenance operations. This is especially the case for bridges across Japan. With a large number of bridges constructed during the rapid economic growth period, aging simultaneously, extensive inspection data and repair histories have been managed disparately across paper ledgers or departmental systems thus far, leading to inadequate integration between the experience of skilled engineers and digital data.
To address this inefficiency, it is vital to leverage cutting-edge ...
Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options remain limited once the disease progresses after first-line chemotherapy, and survival rarely exceeds one year.
To address this, the team of researchers led by Professor Yun Hak Kim from Pusan National University, analyzed 12 years of clinical data from 54 patients treated at Yonsei Severance Hospital and combined the results with a systematic review and meta-analysis of 21 studies from around the world. This paper was made available ...
A comprehensive new analysis by researchers at Queen Mary University of London warns that England has lost the substantial gains made in high blood pressure prevention, diagnosis and management during the 2000s.
Drawing on data from more than 67,000 adults who participated in the annual Health Survey for England between 2003 and 2021, researchers report that the rates of high blood pressure, undiagnosed hypertension and inadequate treatment control have plateaued since 2011 and deteriorated sharply in the aftermath of the Covid-19 pandemic.
Findings ...
Life’s instructions are written in DNA, but it is the enzyme RNA polymerase II (Pol II) that reads the script, transcribing RNA in eukaryotic cells and eventually giving rise to proteins. Scientists know that Pol II must advance down the gene in perfect sync with other biological processes; aberrations in the movement of this enzyme have been linked to cancer and aging. But technical hurdles prevented them from precisely determining how this important molecular machine moves along DNA, and what governs its pauses and accelerations.
A new ...
Key Findings
Drones can be a valuable, non-invasive tool for observing elephant families and aiding long-term conservation efforts.
Elephants can habituate to drones - showing fewer signs of disturbance both during a single flight and after repeated exposures. Disturbance behaviours were 70% less likely on successive drone flights.
Careful flight protocols matter - when flown high (120 m or above), with a downwind approach, and steadily, drones cause minimal stress.
Just under half of all trials showed no signs of disturbance, and those that did quickly returned to levels comparable with pre-exposure.
The ...
Press Release
Under embargo until 27 November, 11:00 AM, CET
RNA in action: filming ribozyme self-assembly
Researchers have visualised, in unprecedented detail, how a large RNA molecule assembles itself into a functional machine
RNA is a central biological macromolecule, now widely harnessed in medicine and nanotechnology. Like proteins, RNA function often depends on its precise three-dimensional structure. A recent study published in Nature Communications by Marcia group, has captured, for the first time, a ribozyme in ...
The nucleus accumbens is a tiny element of the human brain triggered when we experience something enjoyable, and used to help us learn behaviours that lead to rewards.
A new study has shown for the first time that its influence on human behaviour can be altered using transcranial ultrasound stimulation (TUS).
Applying the technique for just over a minute at a time, researchers were able to influence how people learned the links between certain cues and rewards.
The result was that they were more likely to repeat a choice that had previously paid off, their learning rates following positive outcomes increased and they were more likely to make ...
An international team of researchers led by the Francis Crick Institute, working with the Paul Scherrer Institute, have developed a new imaging protocol to capture mouse brain cell connections in precise detail.
In work published today in Nature Methods, they combined the use of X-rays with radiation-resistant materials sourced from the aerospace industry.
The images acquired using this technique allowed the team to see how nerve cells connect in the mouse brain, without needing to thinly slice biological tissue samples.
Volume electron microscopy (volume EM) has been the gold standard for imaging how nerve cells connect as ‘circuitry’ ...
A new review published in Frontiers in Science is calling for urgent action to avoid irreversible ecological damage by stemming the tide of microplastics entering the environment.
Climate change conditions turn plastics into more mobile, persistent, and hazardous pollutants. This is done by speeding up plastic breakdown into microplastics - microscopic fragments of plastic - spreading them considerable distances, and increasing exposure and impact within the environment.
This is set to worsen as both plastic manufacturing and climate effects increase. Global annual plastic ...
Europe is failing to test and treat HIV early, with over half (54%) of all diagnoses in 2024 being made too late for optimal treatment. New data released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe warns that this critical testing failure, combined with a growing number of undiagnosed cases, is severely jeopardising the 2030 goal of ending AIDS as a public health threat.
According to the annual HIV/AIDS surveillance report, 105 922 HIV diagnoses were made in the ...
